- Home
- News
- Topics
- FDA Week
- Inside CMS
- Inside Drug Pricing
- Health Exchange Alert
- Inside TeleHealth
- About Us
From: News, FDA
Sent: Wednesday, November 27, 2002 11:50 AM
To: FDA-Wide Metro
Subject: Appointment of Assistant Commissioner for Regulatory Affairs
FOR IMMEDIATE RELEASE
P02-51
November 27, 2002
Media Inquiries: 301-827-6242
Consumer Inquiries: 888-INFO-FDA
FDA has approved Claritin (loratadine) as an over-the-counter (OTC) allergy drug product. Previously available only as a prescription drug, Claritin is approved for seasonal allergic rhinitis -- a condition that causes runny nose, nasal congestion, sneezing, and itchy nose, throat, eyes, and ears.